Latest news with #Genius'
Yahoo
5 days ago
- Business
- Yahoo
VERSES® Announces Major Global Investment Firm Upgrades to Genius™ Enterprise Based on Early Project Success
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company'), a cognitive computing company specializing in next-generation agentic software systems, announces that a major global investment firm has converted to an enterprise contract with the Company on the basis of the results achieved during its participation in the Company's Genius beta program. This firm validated Genius beta in early 2025 and based on the initial results, it has signed up for a renewable enterprise license, which provides it with access to unlimited inferences. The contract contains provisions for outcome-based pricing in the future, after an initial period of fixed payments. Genius, which uses active inference models and techniques that are particularly well-suited to handling complex, layered reasoning, is being explored to be used as an alternative to current AI. 'We are thrilled at the early results of Genius and believe that the migration from the Genius beta program to the Genius commercial Enterprise version is a strong vote of confidence in Genius' potential,' said Michael Wadden, VERSES' Chief Commercial Officer. 'We are excited by the opportunity to unlock significant business value with one of the largest global financial institutions as we begin to scale Genius into the market.' About VERSESVERSES® is a cognitive computing company focused on building next-generation intelligent software systems modelled after the wisdom and genius of nature. Designed around first principles found in science, physics and biology, the Company's flagship product, Genius,™ is an agentic enterprise intelligence platform designed to generate reliable domain-specific predictions and decisions under uncertainty. Learn more at LinkedIn and X. On behalf of the Company Gabriel René, Founder & CEO, VERSES AI Inc. Press Inquiries: press@ Investor Relations Inquiries James Christodoulou, Chief Financial OfficerIR@ +1(212)970-8889 Cautionary Note Regarding Forward-Looking Statements This news release contains statements which constitute 'forward-looking information' or 'forward-looking statements' within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information and forward-looking statements are often identified by the words 'may', 'would', 'could', 'should', 'will', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' or similar expressions. More particularly and without limitation, this news release contains forward–looking statements and information relating to the potential of Genius to provide value to clients. The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that such plans will be completed as proposed or at all. Such forward-looking statements are based on a number of assumptions of management. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward–looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Business Upturn
5 days ago
- Business
- Business Upturn
VERSES® Announces Major Global Investment Firm Upgrades to Genius™ Enterprise Based on Early Project Success
By GlobeNewswire Published on June 5, 2025, 17:54 IST VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ('VERSES' or the 'Company'), a cognitive computing company specializing in next-generation agentic software systems, announces that a major global investment firm has converted to an enterprise contract with the Company on the basis of the results achieved during its participation in the Company's Genius beta program. This firm validated Genius beta in early 2025 and based on the initial results, it has signed up for a renewable enterprise license, which provides it with access to unlimited inferences. The contract contains provisions for outcome-based pricing in the future, after an initial period of fixed payments. Genius, which uses active inference models and techniques that are particularly well-suited to handling complex, layered reasoning, is being explored to be used as an alternative to current AI. 'We are thrilled at the early results of Genius and believe that the migration from the Genius beta program to the Genius commercial Enterprise version is a strong vote of confidence in Genius' potential,' said Michael Wadden, VERSES' Chief Commercial Officer. 'We are excited by the opportunity to unlock significant business value with one of the largest global financial institutions as we begin to scale Genius into the market.' About VERSES VERSES® is a cognitive computing company focused on building next-generation intelligent software systems modelled after the wisdom and genius of nature. Designed around first principles found in science, physics and biology, the Company's flagship product, Genius,™ is an agentic enterprise intelligence platform designed to generate reliable domain-specific predictions and decisions under uncertainty. Learn more at , LinkedIn and X . On behalf of the Company Gabriel René, Founder & CEO, VERSES AI Inc. Press Inquiries: [email protected] Investor Relations Inquiries James Christodoulou, Chief Financial Officer [email protected] , +1(212)970-8889 Cautionary Note Regarding Forward-Looking Statements This news release contains statements which constitute 'forward-looking information' or 'forward-looking statements' within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information and forward-looking statements are often identified by the words 'may', 'would', 'could', 'should', 'will', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' or similar expressions. More particularly and without limitation, this news release contains forward–looking statements and information relating to the potential of Genius to provide value to clients. The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that such plans will be completed as proposed or at all. Such forward-looking statements are based on a number of assumptions of management. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward–looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
&w=3840&q=100)
Business Standard
6 days ago
- Business
- Business Standard
China really wants to attract talented scientists. Trump just helped
China was already scoring wins in its rivalry with the United States for scientific talent. It had drawn some of the world's best researchers to its campuses, people decorated with Nobel Prizes, MacArthur 'Genius' grants and seemingly every other academic laurel on offer. Now the Trump administration's policies might soon bolster China's efforts. Under President Trump, the United States is slashing the research funding that helped establish its reputation as the global leader in science and technology. The president is also attacking the country's premier universities, and trying to limit the enrollment of international students. Scientists from China are under particular pressure, as U.S. officials have said that they may pose a national security threat by funneling valuable knowledge to China. Chinese-born scientists have been investigated or even arrested. Last week, the Trump administration said it would work to 'aggressively revoke' the visas of Chinese students in 'critical fields.' And Chinese institutions have been quick to try and capitalize. Universities in Hong Kong and Xi'an said they would offer streamlined admission to transfer students from Harvard. An ad from a group with links to the Chinese Academy of Sciences welcomed 'talents who have been dismissed by the U.S. NIH,' or National Institutes of Health. 'The United States is shooting itself in the foot,' said Zhang Xiaoming, an anatomy expert who last year left the Baylor College of Medicine, in Texas, to lead the medical education program at Westlake University, a research university in the tech hub of Hangzhou. 'Since I went to the United States more than 30 years ago, so much of its research has been supported by foreigners, including many Chinese,' said Professor Zhang, who emphasized that he was speaking for himself, not his employer. 'Without foreigners, at least in the field of scientific research, they can't go on.' On its own, China had become more attractive to scientists in recent years because of the huge investments the country has made in research. Westlake is a prime example. Established in 2018 by several high-profile scientists who had themselves returned to China from the West, Westlake's campus exudes technological advancement. A spaceship-like tower looms over rows of research laboratories. Computing centers and animal testing facilities cluster around a central lawn, in a shape designed to evoke a biological cell. In its main academic building, portraits of dozens of professors are on display — all of whom were recruited from overseas. There is Guan Kunliang, a biochemist who won a MacArthur 'Genius' grant while in Michigan; Cheng Jianjun, a materials engineer honored multiple times by the National Science Foundation; Yu Hongtao, a Harvard-educated cell biologist who received millions in funding from the Howard Hughes Medical Institute in Maryland. Recruitment notices advertise high compensation, in line with those at top foreign universities. Westlake has been perhaps the most successful Chinese university at recruiting overseas talent, but it is far from the only one. Between 2010 and 2021, nearly 12,500 scientists of Chinese descent left the United States for China, according to a study published in Proceedings of the National Academy of Sciences. The rate of departure was accelerating: More than half of them left in just the five years between 2017 and 2021. The trend has only continued in the last few years, said Yu Xie, a professor at Princeton University who coauthored the study. Nor is it only Chinese-born scientists who are jumping ship. Charles Lieber, a former Harvard chemist who was convicted in 2023 of failing to disclose payments from a Chinese university, recently joined Tsinghua University. Chinese scientists have long flocked to American universities, lured by the promise of a world-class education and resources that their home country could not provide. In the 1980s, Chinese scientists who visited the United States would collect disposable test tubes to reuse in China, said Rao Yi, a neurobiologist at Peking University in Beijing, who studied and worked in the United States for two decades. The admiration continued even as China's economy boomed. In 2020, nearly one-fifth of Ph.D.s in science, technology, engineering and mathematics awarded in the United States went to students from China, according to data from the National Science Foundation. Historically, the vast majority of those Ph.D.s stayed in the United States — 87 percent between 2005 and 2015, the data showed. Many became U.S. citizens, and they have helped the United States accumulate patents, publications and Nobel Prizes. But in recent years, more scientists have been returning to China, drawn partly by government recruitment programs promising them millions of dollars in funding as well as housing subsidies and other perks. China's spending on research and development is now second only to the United States. And Chinese institutions such as Tsinghua and Zhejiang University now routinely rank among the best in the world for science and technology. The investment is part of a plan to turn China into a scientific superpower, especially in strategically important fields such as artificial intelligence, semiconductors and biotechnology. 'The scientific and technological revolution is intertwined with the game between superpowers,' China's leader, Xi Jinping, said last year. At the same time, the United States has been pushing scientists away for years, in particular by investigating their ties with China. Lu Wuyuan, a protein chemist formerly at the University of Maryland, was one of those targeted. He was investigated by the National Institutes of Health for allegedly failing to disclose research ties to China — ties he said Maryland knew about. After 20 years at the university, he quit in 2020. Most of the cases brought under the so-called China Initiative eventually collapsed. Many researchers criticized the campaign as racial profiling. Professor Lu, who now works at Fudan University in Shanghai, said that many of his friends mused about leaving the United States, but most chose to stay because they had built lives there. The Trump administration's assault on research funding may change that. 'If they cut so much funding, I believe that may be the last straw for many people,' Professor Lu said. Still, China faces its own issues in poaching talent. It has become harder for Chinese universities to meet and woo overseas scientists, as Chinese scholars have had trouble securing visas to the United States to attend academic conferences. Researchers in America also face restrictions in visiting China; Texas, for example, prohibits employees of public universities from traveling to China for work. The scientists who have returned to China largely fall into a few categories: those who are early in their careers, or who are nearing retirement, or who felt pushed out by investigations. Established midcareer scholars are still reluctant to leave, multiple scientists said. Professor Rao at Peking University, who was also one of Westlake's co-founders, said that China's progress in recruiting international talent had also been hampered by jealousy among domestic colleagues. 'While funding should increase, it is not the key factor at this stage,' Professor Rao said. 'Supporting scientists based on merit and their good science is the key.' And even at home, scientists are not spared political scrutiny. Chinese universities face limits on free expression, and China's Ministry of State Security has warned that scholars returning from overseas may be spies. Multiple Chinese-born scientists — both those who had returned to China, and those still in the United States — emphasized that they did not want to get entangled in politics. They were just trying to do good work. The simple fact was, many agreed, that it was increasingly easier to do so in China. 'It's hard to survive in America. And China is developing so fast,' said Fu Tianfan, 32, an artificial intelligence researcher who left Rensselaer Polytechnic Institute in December to join Nanjing University. 'Whether it was the best choice,' he said, 'it may take some time to say.'
Straits Times
6 days ago
- Business
- Straits Times
China really wants to attract talented scientists, Trump just helped
Last week, the Trump administration said it would work to 'aggressively revoke' the visas of Chinese students in 'critical fields'. PHOTO: AFP China really wants to attract talented scientists, Trump just helped HANGZHOU – China was already scoring wins in its rivalry with the United States for scientific talent. It had drawn some of the world's best researchers to its campuses, people decorated with Nobel Prizes, MacArthur 'Genius' grants and seemingly every other academic laurel on offer. Now the Trump administration's policies might soon bolster China's efforts. Under President Donald Trump, the United States is slashing the research funding that helped establish its reputation as the global leader in science and technology. The president is also attacking the country's premier universities, and trying to limit the enrollment of international students. Scientists from China are under particular pressure, as US officials have said that they may pose a national security threat by funneling valuable knowledge to China. Chinese-born scientists have been investigated or even arrested. Last week, the Trump administration said it would work to 'aggressively revoke' the visas of Chinese students in 'critical fields'. As a result, many scholars are looking elsewhere. And Chinese institutions have been quick to try to capitalise. Universities in Hong Kong and Xi'an said they would offer streamlined admission to transfer students from Harvard University. An ad from a group with links to the Chinese Academy of Sciences welcomed 'talents who have been dismissed by the US NIH,' or National Institutes of Health. 'The United States is shooting itself in the foot,' said anatomy expert Zhang Xiaoming, who in 2024 left the Baylor College of Medicine, in Texas, to lead the medical education program at Westlake University, a research university in the tech hub of Hangzhou. 'Since I went to the United States more than 30 years ago, so much of its research has been supported by foreigners, including many Chinese,' said Dr Zhang, who emphasised that he was speaking for himself, not his employer. 'Without foreigners, at least in the field of scientific research, they can't go on.' On its own, China had become more attractive to scientists in recent years because of the huge investments the country has made in research. Westlake is a prime example. Established in 2018 by several high-profile scientists who had returned to China from the West, Westlake's campus exudes technological advancement. A spaceshiplike tower looms over rows of research laboratories. Computing centers and animal testing facilities cluster around a central lawn, in a shape designed to evoke a biological cell. In its main academic building, portraits of dozens of professors are on display – all of whom were recruited from overseas. There is Dr Guan Kunliang, a biochemist who won a MacArthur 'Genius' grant while in Michigan; Dr Cheng Jianjun, a materials engineer honored multiple times by the National Science Foundation; Dr Yu Hongtao, a Harvard-educated cell biologist who received millions in funding from the Howard Hughes Medical Institute in Maryland. Recruitment notices advertise high compensation, in line with those at top foreign universities. Westlake has been perhaps the most successful Chinese university at recruiting overseas talent, but it is far from the only one. Between 2010 and 2021, nearly 12,500 scientists of Chinese descent left the United States for China, according to a study published in Proceedings of the National Academy of Sciences. The rate of departure was accelerating: More than half of them left in just the five years between 2017 and 2021. The trend has only continued in the past few years, said Professor Yu Xie from Princeton University who co-authored the study. Nor is it only Chinese-born scientists who are jumping ship. Former Harvard chemist Charles Lieber, who was convicted in 2023 of failing to disclose payments from a Chinese university, recently joined Tsinghua University. Chinese scientists have long flocked to American universities, lured by the promise of a world-class education and resources that their home country could not provide. In the 1980s, Chinese scientists who visited the United States would collect disposable test tubes to reuse in China, said neurobiologist Rao Yi at Peking University in Beijing, who studied and worked in the United States for two decades. The admiration continued even as China's economy boomed. In 2020, nearly one-fifth of doctorates in science, technology, engineering and mathematics awarded in the United States went to students from China, according to data from the National Science Foundation. Historically, the vast majority of those doctorates stayed in the United States – 87 per cent between 2005 and 2015, the data showed. Many became US citizens, and they have helped the United States accumulate patents, publications and Nobel Prizes. In recent years, more scientists have been returning to China, drawn partly by government recruitment programs promising them millions of dollars in funding as well as housing subsidies and other perks. China's spending on research and development is now second only to the United States. And Chinese institutions such as Tsinghua and Zhejiang University now routinely rank among the best in the world for science and technology. The investment is part of a plan to turn China into a scientific superpower, especially in strategically important fields such as artificial intelligence, semiconductors and biotechnology. 'The scientific and technological revolution is intertwined with the game between superpowers,' China's leader Xi Jinping said in 2024. At the same time, the United States has been pushing scientists away for years, in particular by investigating their ties with China. Protein chemist Lu Wuyuan, formerly at the University of Maryland, was one of those targeted. He was investigated by the National Institutes of Health for allegedly failing to disclose research ties to China – ties he said Maryland knew about. After 20 years at the university, he quit in 2020. Most of the cases brought under the so-called China Initiative eventually collapsed. Many researchers criticised the campaign as racial profiling. Dr Lu, who now works at Fudan University in Shanghai, said that many of his friends mused about leaving the United States, but most chose to stay because they had settled there. The Trump administration's assault on research funding may change that. 'If they cut so much funding, I believe that may be the last straw for many people,' Dr Lu said. Still, China faces its own issues in poaching talent. It has become harder for Chinese universities to meet and woo overseas scientists, as Chinese scholars have had trouble securing visas to the United States to attend academic conferences. Researchers in America also face restrictions in visiting China; Texas, for example, prohibits employees of public universities from traveling to China for work. The scientists who have returned to China largely fall into a few categories: those who are early in their careers, or who are nearing retirement, or who felt pushed out by investigations. Established midcareer scholars are still reluctant to leave, multiple scientists said. Dr Rao at Peking University, who was also one of Westlake's co-founders, said that China's progress in recruiting international talent had also been hampered by cronyism and jealousy among domestic colleagues. 'While funding should increase, it is not the key factor at this stage,' Dr Rao said. 'Supporting scientists based on merit and their good science is the key.' Even at home, scientists are not spared political scrutiny. Chinese universities face limits on free expression, and China's Ministry of State Security has warned that scholars returning from overseas may be spies. Multiple Chinese-born scientists – both those who had returned to China, and those still in the United States – emphasised that they did not want to get entangled in politics. They were just trying to do good work. The simple fact was, many agreed, that it was increasingly easier to do so in China. 'It's hard to survive in America. And China is developing so fast,' said artificial intelligence researcher Fu Tianfan, 32, who left Rensselaer Polytechnic Institute in December 2024 to join Nanjing University. 'Whether it was the best choice,' he said, 'it may take some time to say.' NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
The Market Online
30-04-2025
- Business
- The Market Online
Verses launches Genius AI out of beta to commercial product
Cognitive computing company Verses AI (CBOE:VERS) announced the commercial launch of its flagship product, Genius This platform is designed to enable Agentic Intelligence for enterprise applications, offering machine learning and data science professionals tools to tackle complex problems involving prediction with uncertainty or hidden factors The launch of Genius comes with significant upgrades and enhancements to its existing features, making it a comprehensive solution for enterprise intelligence Verses AI stock (CBOE:VERS) last traded at C$4.10 Cognitive computing company Verses AI (CBOE:VERS) announced the commercial launch of its flagship product, Genius. This platform is designed to enable Agentic Intelligence for enterprise applications, offering machine learning and data science professionals new tools to tackle complex problems involving prediction with uncertainty or hidden factors. Genius: A new era of intelligent enterprise solutions Genius aims to shift the landscape of enterprise intelligence with its advanced features and capabilities. The platform will be available as a paid service, offering flexible pricing plans that include consumption-based and performance-based options, as well as enterprise licenses. This approach ensures that organizations of all sizes can leverage Genius' capabilities according to their specific needs and usage patterns. Key features and enhancements The launch of Genius comes with significant upgrades and enhancements to its existing features, making it a comprehensive solution for enterprise intelligence. Key features include: Intelligent agents : Autonomous agents that can perform complex tasks and make decisions based on real-time data. : Autonomous agents that can perform complex tasks and make decisions based on real-time data. Model editor : A sophisticated tool for creating, editing, and optimizing machine learning models. : A sophisticated tool for creating, editing, and optimizing machine learning models. Application programming interfaces (APIs) : Robust APIs that facilitate seamless integration with existing enterprise systems. : Robust APIs that facilitate seamless integration with existing enterprise systems. Developer portal: A dedicated portal providing resources, documentation, and support for developers. A full list of models and capabilities is available on Verses' website. Transition from beta to commercial use Verses AI will be converting its current beta users into paying customers, marking a significant milestone in the platform's development. The company expects to begin rolling out access to qualified applicants from the thousands of developer sign-ups in the coming weeks. This transition underscores the platform's readiness for widespread adoption and its potential to drive innovation in enterprise intelligence. Target audience and pricing plans Genius' initial target audience includes machine learning and data science professionals who are focused on solving enterprise problems. The platform's flexible pricing plans cater to researchers, professionals, and enterprises, ensuring that users can select the plan that best fits their needs. Leadership insights 'With today's milestone, the commercial launch of Genius, VERSES transitions from research-led to revenue-driven,' Verses' CEO and founder, Gabriel René said in a news release. 'Enterprises face constant pressure to increase productivity, reduce costs, maintain competitive advantage, and manage risk—and they want to use AI Agents to help make smarter predictions and automate decisions that reflect their company's unique business and operational domain.' With the launch of Genius, Verses is in a position to redefine the standards of enterprise intelligence. The platform's advanced features and flexible pricing plans make it an attractive option for organizations looking to harness the power of Agentic Intelligence. About Verses AI Verses AI is a cognitive computing stock building next-generation intelligent software systems. Its flagship Genius product offers tools for machine learning practitioners to model and generate autonomous intelligent agents that reason, plan and learn in real time. Verses AI stock (CBOE:VERS) last traded at C$4.10 Join the discussion: Find out what everybody's saying about this AI technology stock on the Verses AI Inc. Bullboard and check out Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here. (Top image via Verses AI.)
